Psyched Wellness

Psyched Wellness EBITDA per Share

The EBITDA per Share of Psyched Wellness (PSYC.CN) as of Oct 26, 2026 is -0.02 CAD. In the previous year, EBITDA per Share was -0.02 CAD — a change of 11.85% (lower).

EBITDA per Share

-0.02CAD

YoY

11.85%

Last updated:

EBITDA per Share of Psyched Wellness is 2025 -0.02 CAD. EBITDA per Share of Psyched Wellness was 2024 -0.02 CAD. It decreases by 11.85% lower compared to the previous year.

The Psyched Wellness EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.07 CAD
Jan 1, 2019
-0.04 CAD
Jan 1, 2020
-0.03 CAD
Jan 1, 2021
-0.03 CAD
Jan 1, 2022
-0.03 CAD
Jan 1, 2023
-0.01 CAD
Jan 1, 2024
-0.02 CAD
Jan 1, 2025
-0.02 CAD
The Psyched Wellness EBITDA per Share history
YEAREBITDA per ShareYoY
-0.02CAD+11.85%
-0.02CAD+10.73%
-0.01CAD-52.76%
-0.03CAD-12.73%
-0.03CAD+13.76%
-0.03CAD-20.75%
-0.04CAD-44.15%
-0.07CAD+62.88%
-0.04CAD+3,302.85%
-0.00CAD+0.81%
-0.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psyched Wellness Stock analysis

What does Psyched Wellness do? Psyched Wellness Ltd. distributes mushroom-derived products and associated consumer packaged goods, focusing on organic, natural, and lab-tested solutions for global health and wellness. The company develops Amanita muscaria-derived water-based extracts, teas, and capsules to reduce stress, ease muscular tension, and promote restorative sleep. Its wholly owned subsidiary, Psyched Wellness Corp, supports these product lines. The firm targets health-conscious consumers seeking natural wellness solutions through its branded offerings. The company's revenue streams come from the sale of mushroom-based supplements and consumer goods, with a focus on Amanita muscaria products for stress relief and sleep enhancement. Psyched Wellness Corp, as the subsidiary, likely handles distribution and product development for the main brand. The primary customer segment consists of individuals prioritizing natural health remedies over conventional pharmaceuticals. Psyched Wellness Ltd. positions itself as a provider of innovative, lab-tested mushroom products, emphasizing organic and natural ingredients. The firm's product range includes water-based extracts, teas, and capsules derived from Amanita muscaria, targeting users interested in stress reduction and improved sleep quality. Sales occur through direct-to-consumer channels for its branded wellness products. Psyched Wellness is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psyched Wellness stock

EBITDA per Share of Psyched Wellness is -0.02 CAD in 2025.

EBITDA per Share of Psyched Wellness changed from -0.02 CAD to -0.02 CAD, representing a 11.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Psyched Wellness since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Psyched Wellness

All Key Metrics — Psyched Wellness